BACKGROUND AND OBJECTIVE: The mainstay of treatment for acute bronchiolitis remains
supportive care. The objective of this study was to assess the efficacy and safety of …

Nebulized hypertonic saline (HS) treatment reduced the length of hospitalization in infants
with acute bronchiolitis in a previous meta-analysis. However, there was no reduction in the …

Aim Acute bronchiolitis is the commonest cause for hospitalisation in infancy. Supportive
care remains the cornerstone of current management and no other therapy has been shown …

Objectives To investigate whether nebulised hypertonic saline (HS) treatment would
decrease length of hospital stay (LOS) among infants with moderate-to severe-bronchiolitis …

Importance Acute bronchiolitis is the most frequent lower respiratory tract infection in infants,
yet there are no effective therapies available. Current evidence is unclear about the role of …

Aim This meta‐analysis aimed to assess the efficacy of nebulized hypertonic saline (HS) on
the rate of hospitalization in infants with acute bronchiolitis in the Emergency Department …

Background Acute bronchiolitis is the commonest cause of hospitalisation in infancy.
Currently management consists of supportive care and oxygen. A Cochrane review …

Abstract Background To Assess the efficacy of nebulised hypertonic saline (HS)(3%) among
children with mild to moderately severe bronchiolitis. Methods Infants aged 6 weeks to 24 …

Importance Bronchiolitis is one of the most common and costly respiratory diseases in
infants and young children. Previous studies have shown a potential benefit of nebulized …

Bronchiolitis, an infection of the lower respiratory tract, is the leading cause of infant and
child hospitalization in the United States. Therapeutic options for management of …